Login / Signup

Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.

Uzma ChaudhryRasmus BorgquistJ Gustav SmithDavid Mörtsell
Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
Our study confirms the clinical efficacy of an antibacterial envelope in the prevention of local CIED infection in patients with a higher risk according to the PADIT score. In an effort to improve cost-benefit ratios, ration of use guided by the PADIT score is advocated. Further prospective randomized studies in high-risk populations are called for.
Keyphrases
  • silver nanoparticles
  • open label
  • double blind
  • left ventricular
  • phase iii
  • anti inflammatory
  • randomized controlled trial
  • placebo controlled
  • clinical trial
  • essential oil